Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson's Disease: Preclinical and Clinical Studies.
Cells
; 11(21)2022 11 02.
Article
in En
| MEDLINE
| ID: mdl-36359864
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Gastrointestinal Microbiome
Limits:
Animals
Language:
En
Journal:
Cells
Year:
2022
Document type:
Article
Affiliation country:
Taiwán
Country of publication:
Suiza